pembrolizumab,bevacizumab
merck,roche
['gyn', 'beva', 'keynote-826', 'bevacizumab', 'pembro']
 updated keynote-826 results at #asco22 by dr. tewari as a reminder, this study demonstrated improved progression free and overall survival in recurrent #cervicalcancer with the addition of pembrolizumab (#immunotherapy) to chemotherapy +/- bevacizumab #gyncsm 
Gyn Onc at MD Anderson. She/Hers. Wife of @DrJasonWestin. Innovative clinical trials. #JCO social media editor. Opinions=mine.
https://t.co/QLXLDKSThc